15-42409972-C-T

Variant names:

• chr15-42409972-C-T
• rs764370512
• ENST00000673743:c.-6C>T

Variant summary

Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PP3_Strong PP5_Very_Strong

The ENST00000673743(CAPN3):​c.-6C>T variant causes a 5 prime UTR premature start codon gain change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000496 in 1,612,032 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★).

• Frequency:
  • Genomes: 𝑓 0.000013 (0 hom., cov: 31)
  • Exomes 𝑓: 0.0000041 (0 hom.)
• Consequence: CAPN3 ENST00000673743 5_prime_UTR_premature_start_codon_gain
• Clinical Significance: Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:7 U:1
• Conservation: PhyloP100: 3.17

Genes affected

CAPN3 (HGNC:1480): (calpain 3) Calpain, a heterodimer consisting of a large and a small subunit, is a major intracellular protease, although its function has not been well established. This gene encodes a muscle-specific member of the calpain large subunit family that specifically binds to titin. Mutations in this gene are associated with limb-girdle muscular dystrophies type 2A. Alternate promoters and alternative splicing result in multiple transcript variants encoding different isoforms and some variants are ubiquitously expressed. [provided by RefSeq, Jul 2008]

ENSG00000258461 (HGNC:):

ACMG classification

Verdict is Pathogenic. Variant got 12 ACMG points.

• PP3: MetaRNN computational evidence supports a deleterious effect, 0.984
• PP5: Variant 15-42409972-C-T is Pathogenic according to our data. Variant chr15-42409972-C-T is described in ClinVar as [Likely_pathogenic]. Clinvar id is 285572.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr15-42409972-C-T is described in Lovd as [Pathogenic]. Variant chr15-42409972-C-T is described in Lovd as [Pathogenic]. Variant chr15-42409972-C-T is described in Lovd as [Likely_pathogenic].

Transcripts

RefSeq

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	MANE	Protein	UniProt
CAPN3	NM_000070.3	c.2092C>T	p.Arg698Cys	missense_variant	Exon 19 of 24	ENST00000397163.8	NP_000061.1

Ensembl

Gene	Transcript	HGVSc	HGVSp	Effect	Exon rank	TSL	MANE	Protein	Appris	UniProt
CAPN3	ENST00000673743	c.-6C>T		5_prime_UTR_premature_start_codon_gain_variant	Exon 6 of 11			ENSP00000500989.1
CAPN3	ENST00000397163.8	c.2092C>T	p.Arg698Cys	missense_variant	Exon 19 of 24	1	NM_000070.3	ENSP00000380349.3
CAPN3	ENST00000673886.1	c.97C>T	p.Arg33Cys	missense_variant	Exon 6 of 11			ENSP00000501155.1
CAPN3	ENST00000673928.1	c.97C>T	p.Arg33Cys	missense_variant	Exon 6 of 11			ENSP00000501099.1
CAPN3	ENST00000674146.1	c.97C>T	p.Arg33Cys	missense_variant	Exon 7 of 12			ENSP00000501175.1
CAPN3	ENST00000674149.1	c.97C>T	p.Arg33Cys	missense_variant	Exon 6 of 11			ENSP00000501112.1
CAPN3	ENST00000673743	c.-6C>T		5_prime_UTR_variant	Exon 6 of 11			ENSP00000500989.1
ENSG00000258461	ENST00000495723.1	n.*2528C>T		non_coding_transcript_exon_variant	Exon 21 of 26	2		ENSP00000492063.1
ENSG00000258461	ENST00000495723.1	n.*2528C>T		3_prime_UTR_variant	Exon 21 of 26	2		ENSP00000492063.1

Frequencies

GnomAD3 genomes AF: 0.0000131 AC: 2 AN: 152110 Hom.: 0 Cov.: 31

Gnomad AFR AF: 0.0000241

Gnomad AMI AF: 0.00

Gnomad AMR AF: 0.00

Gnomad ASJ AF: 0.00

Gnomad EAS AF: 0.00

Gnomad SAS AF: 0.00

Gnomad FIN AF: 0.00

Gnomad MID AF: 0.00

Gnomad NFE AF: 0.0000147

Gnomad OTH AF: 0.00

GnomAD3 exomes AF: 0.0000159 AC: 4 AN: 251334 Hom.: 0 AF XY: 0.0000221 AC XY: 3 AN XY: 135834

Gnomad AFR exome AF: 0.00

Gnomad AMR exome AF: 0.0000289

Gnomad ASJ exome AF: 0.00

Gnomad EAS exome AF: 0.00

Gnomad SAS exome AF: 0.00

Gnomad FIN exome AF: 0.00

Gnomad NFE exome AF: 0.0000264

Gnomad OTH exome AF: 0.00

GnomAD4 exome AF: 0.00000411 AC: 6 AN: 1459922 Hom.: 0 Cov.: 34 AF XY: 0.00000688 AC XY: 5 AN XY: 726256

Gnomad4 AFR exome AF: 0.00

Gnomad4 AMR exome AF: 0.0000224

Gnomad4 ASJ exome AF: 0.00

Gnomad4 EAS exome AF: 0.00

Gnomad4 SAS exome AF: 0.00

Gnomad4 FIN exome AF: 0.00

Gnomad4 NFE exome AF: 0.00000450

Gnomad4 OTH exome AF: 0.00

GnomAD4 genome AF: 0.0000131 AC: 2 AN: 152110 Hom.: 0 Cov.: 31 AF XY: 0.0000135 AC XY: 1 AN XY: 74304

Gnomad4 AFR AF: 0.0000241

Gnomad4 AMR AF: 0.00

Gnomad4 ASJ AF: 0.00

Gnomad4 EAS AF: 0.00

Gnomad4 SAS AF: 0.00

Gnomad4 FIN AF: 0.00

Gnomad4 NFE AF: 0.0000147

Gnomad4 OTH AF: 0.00

Bravo AF: 0.0000113

ExAC AF: 0.0000165 AC: 2

ClinVar

Significance: Conflicting classifications of pathogenicity

Submissions summary: Pathogenic:7 Uncertain:1

Revision: criteria provided, conflicting classifications

Submissions by phenotype

Autosomal recessive limb-girdle muscular dystrophy type 2A Pathogenic:5

May 10, 2017

Counsyl

Significance: Likely pathogenic

Review Status: no assertion criteria provided

Collection Method: clinical testing

- -

Apr 11, 2024

Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: research

The homozygous p.Arg698Cys variant in CAPN3 was identified by our study in two unrelated individuals with limb-girdle muscular dystrophy (LGMD). The p.Arg698Cys variant has also been reported in at least 8 individuals with limb-girdle muscular dystrophy (PMID: 15689361, 17236769, 16650086, 21204801, 28403181, 33250842, 35169782, 35821219), and has been identified in 0.002% (1/59994) of Admixed American chromosomes by the Genome Aggregation Database (gnomAD, http://gnomad.broadinstitute.org; dbSNP rs764370512). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. This variant has also been reported in ClinVar (Variation ID: 285572) and has been interpreted as likely pathogenic/pathogenic by multiple labs. Of the affected individuals, five were compound heterozygotes that carried reported pathogenic variant with unknown phase and two were homozygotes, which increases the likelihood that the p.Arg698Cys variant is pathogenic (Variation ID: 17621, 128570, 468648, 557732, 2680368; PMID: 17236769, 21204801, 28403181, 33250842, 35169782, 35821219). Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. In vitro functional studies provide some evidence that the p.Arg698Cys variant may slightly impact protein function (PMID: 17236769). However, these types of assays may not accurately represent biological function. In summary, although additional studies are required to fully establish its clinical significance, this variant is likely pathogenic for autosomal recessive limb-girdle muscular dystrophy. ACMG/AMP Criteria applied: PM3_strong, PP3_moderate, PM2_supporting, PS3_supporting (Richards 2015). -

Jan 29, 2024

Labcorp Genetics (formerly Invitae), Labcorp

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 698 of the CAPN3 protein (p.Arg698Cys). This variant is present in population databases (rs764370512, gnomAD 0.003%). This missense change has been observed in individual(s) with autosomal recessive limb-girdle muscular dystrophy (PMID: 15689361, 16650086, 21204801, 28403181). ClinVar contains an entry for this variant (Variation ID: 285572). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt CAPN3 protein function with a positive predictive value of 80%. This variant disrupts the p.Arg698 amino acid residue in CAPN3. Other variant(s) that disrupt this residue have been observed in individuals with CAPN3-related conditions (PMID: 16411092, 25135358), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -

Oct 14, 2022

Foundation for Research in Genetics and Endocrinology, FRIGE's Institute of Human Genetics

Significance: Likely pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

A homozygous variation in exon 19 of the CAPN3 gene that results in the amino acid substitution cysteine for arginine at codon 698 was detected. The observed variant reported in the 1000 genomes and gnomAD databases. The in silico predictions of the variant are probably damaging by PolyPhen-2 (HumDiv) and damaging by SIFT and MutationTaster2. The reference codon is conserved across species. -

Mar 07, 2023

Illumina Laboratory Services, Illumina

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

The CAPN3 c.2092C>T (p.Arg698Cys) missense variant results in the substitution of arginine at amino acid position 698 with cysteine. This variant has been reported in the literature in at least six individuals with autosomal recessive limb-girdle muscular dystrophy (LGMD), including in a homozygous state in one individual and in a compound heterozygous state in five individuals (PMID: 16650086; PMID: 17236769; PMID: 21204801; PMID: 28403181; PMID: 33250842; PMID: 35169782). Additionally, two different amino acid substitutions at the same codon (Arg698His, Arg698Pro) have been reported in individuals with LGMD (PMID: 25135358; PMID: 10330340). This variant is reported in the Genome Aggregation Database at a frequency of 0.000029 in the Latino/Admixed American population (version 2.1.1). The c.2092C>T variant is located within EF-hand 2 domain, which has a low rate of benign variation (UniProt:P20807; PMID: 35169782). Based on the available evidence, the c.2092C>T (p.Arg698Cys) variant is classified as pathogenic for limb-girdle muscular dystrophy. -

not provided Pathogenic:1 Uncertain:1

Jan 22, 2016

Eurofins Ntd Llc (ga)

Significance: Uncertain significance

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Jan 03, 2020

Revvity Omics, Revvity

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Muscular dystrophy, limb-girdle, autosomal dominant 4 Pathogenic:1

Dec 02, 2023

Baylor Genetics

Significance: Pathogenic

Review Status: criteria provided, single submitter

Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name	Calibrated prediction	Score	Prediction
AlphaMissense	Pathogenic	0.70
BayesDel_addAF	Pathogenic	0.34	D
BayesDel_noAF	Pathogenic	0.33
CADD	Pathogenic	30
DANN	Pathogenic	1.0
DEOGEN2	Benign	0.26	T;.;.;D;.;.;.;.;.;.;.;.
Eigen	Pathogenic	0.74
Eigen_PC	Uncertain	0.59
FATHMM_MKL	Uncertain	0.88	D
LIST_S2	Pathogenic	0.99	D;D;D;D;D;D;.;D;.;D;.;D
M_CAP	Pathogenic	0.41	D
MetaRNN	Pathogenic	0.98	D;D;D;D;D;D;D;D;D;D;D;D
MetaSVM	Pathogenic	0.87	D
MutationAssessor	Pathogenic	3.7	.;.;.;H;.;.;.;.;.;.;.;.
PrimateAI	Uncertain	0.72	T
PROVEAN	Pathogenic	-6.5	.;D;D;D;D;D;D;.;D;D;D;D
REVEL	Pathogenic	0.94
Sift	Pathogenic	0.0	.;D;D;D;D;D;D;.;D;D;D;D
Sift4G	Pathogenic	0.0	D;D;D;D;D;D;D;D;D;D;D;D
Polyphen		1.0	.;D;D;D;.;.;.;.;.;.;.;.
Vest4		0.99
MutPred		0.93		.;.;.;Gain of catalytic residue at A702 (P = 0.1683);.;.;.;.;.;.;.;.;
MVP		0.95
MPC		0.74
ClinPred		0.96	D
GERP RS		3.9
Varity_R		0.79
gMVP		0.78

Splicing

Name	Calibrated prediction	Score	Prediction
SpliceAI score (max)		0.020		Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Other links and lift over

dbSNP: rs764370512; hg19: chr15-42702170;